Max Healthcare Institute Ltd

Litigation Update

• NCLT hearing adjourned to October 29, 2026 due to paucity of time.
• Order received by the company on September 29, 2026 at 5:45 pm IST.

Max Healthcare Institute Ltd — Trading Window Closure from October 1, 2026 till 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026

Resolutions and key terms

• Purpose: Special resolutions to approve PRSU scheme for employees, CMD remuneration, and MOA alteration.
• Resolution 1 (Special): Approve MHIL PRSU Scheme 2026 for Company employees up to 73,50,000 PRSUs (~0.76%).
• Resolution 2 (Special): Extend MHIL PRSU Scheme 2026 to Subsidiary employees; aggregate ceiling remains 73,50,000.
• Resolution 3 (Special): Approve remuneration for Mr Abhay Soi as CMD; two-year term.
• Resolution 3 (Special) continued: CMD remuneration fixed ₹28,16,92,500; variable up to ₹12,95,78,550 & ₹15,98,19,068.
• Resolution 3 (Special) continued: Cap max annual remuneration within 5% standalone NP or 2.5% consolidated PBT; fixed unchanged.
• Resolution 4 (Special): Alter Main Objects Clause to add medical education, pharmaceuticals, and food services.
• E-voting window: 9:00 am Sep 20, 2026 to 5:00 pm Oct 19, 2026.
• Cut-off date: Friday, Sep 18, 2026 for voting eligibility.
• Results to be announced on or before Oct 22, 2026.
• Shareholder impact: approx 0.76% dilution from PRSU pool; total dilution ~1.79% including ESOP.
• Director note: CMD Abhay Soi is sole executive director; not Independent.

ESG rating update

• ESG rating of 72 assigned by Niche99, indicating 'Leader' category.
• Company did not engage Niche99 for ESG ratings.
• Rating is based on Max Healthcare's public disclosures.
• Intimation received on September 17, 2026 at 6:52 PM IST.
• Rating will be hosted on the company's website.

Meeting Details

• Date: September 21, 2026 (Monday).
• Event: J.P. Morgan India Conference 2026.
• Mode/Type: Physical; One-on-one and group meetings.
• Location: St. Regis, Mumbai.
• Organizer: J.P. Morgan India Conference 2026.

Participants

• Company representatives (management) to participate.

Purpose

• Purpose: investor conference focusing on investor interaction.

Additional Notes

• Schedule subject to change due to exigencies.

Meeting Details

• Date: September 16, 2026; Physical one-on-one and group meetings at The Oberoi, Gurgaon during Jefferies India Forum 2026.

Participants

• Executive Vice President — Company Secretary and Compliance Officer will represent the company.

Purpose

• Purpose: participate in Jefferies' India Forum 2026 for investor interaction.

Additional Notes

• No one-on-one meetings are proposed before or after the conference.

Filing Status

• NCLT hearing on Sep 8, 2026 directed reply within one week.
• Next hearing scheduled for Sep 28, 2026; order copy received Sept 10, 2026.
• Dispute relates to petitions by BRS Capital against Kalinga Hospital Ltd., a subsidiary.

Kalinga Hospital stake infusion

• Target: Kalinga Hospital Ltd (KHL), hospital operator in healthcare sector.
• KHL is a subsidiary of Max Healthcare Institute Ltd.
• Size/scale: not disclosed.
• Related party transaction: Yes; Max Healthcare subscribes to rights shares in KHL.
• Promoter/group interest: Max Healthcare is the promoter.
• Industry: Healthcare (Hospitals).
• Purpose: fund rights issue and consolidate control; stake to ~66.15%.
• Regulatory approvals: not disclosed.
• Timeline: not disclosed.
• Form of consideration: cash subscription for equity shares on rights basis.
• Cost: ₹87.87 crore.
• Shares allotted: 50,21,212; stake rises to ~66.15% (from ~58.28%).
• Background: hospital operator; incorporation date and turnover history not disclosed.